Carcinogenic HPV Type Has Highest Rate of Incidence and Lowest Rate of Clearance
When it comes to HPV infection in men who have sex with men, the type of virus they contract has real implications for their future cancer risk.
UK Implements Use of Adjuvanted Trivalent Influenza Vaccine for Adults Over 65
Public Health England recommends individuals at higher risks for influenza receive a newly available adjuvanted trivalent influenza vaccine this winter.
Research Reveals Potential New Marker for Mortality Due to Clostridium difficile Infection
A new study is the first to identify eosinophil counts as a predictor of outcomes in human patients.
Screening During Pregnancy Reduces the Incidence of Congenital Syphilis
The US Preventative Services Task Force recommends early screening for syphilis in pregnant women and a literature review has reinforced the recommendations.
Phase 1 Clinical Trial to Assess if a Topical Cream Can Enhance Response to H5N1 Flu Vaccine
Investigators from the NIH have launched a phase 1 clinical trial to assess if a topical cream administered prior to H5N1 vaccination can enhance immune response.
Seattle HIV Case Cluster Stark Reminder of Risks to Homeless: Public Health Watch
Local officials tout benefits of needle exchange, testing programs at reducing risk.
The Forgotten Factors of Antimicrobial Resistance
A new study underscores components to antimicrobial resistance that we may be ignoring.
Second-Line Drugs Can Successfully Treat Children with Multidrug-Resistant TB
An international literature review indicates that 78% of children with multidrug-resistant tuberculosis were successfully treated with second-line treatment.
Integrated Intervention Increases Use of HIV Therapy in People Who Inject Drugs
In a new study, investigators found that providing guidance and advice in people who inject drugs increased use of antiretroviral medication use by 30%.
Shell Eggs Linked with Another Salmonella Outbreak, Prompting Recall
The CDC and FDA are investigating a multistate outbreak of Salmonella Enteritidis linked with Gravel Ridge Farms shell eggs.
New Tool May Enable Real-Time Surveillance of Drug-Resistant Tuberculosis
A team of investigators have discovered a new way to link samples submitted for TB testing to individuals who provided them as well as where the sample was collected.
Dexamethasone Slows Fungal Clearance, Results in Poor Outcomes in HIV-Associated Meningitis
Study results suggest that treatment with the anti-inflammatory steroid dexamethasone is associated with slowed clearance of fungal infections in HIV-associated cryptococcal meningitis.
Probiotic Supplements After Antibiotics May Do More Harm Than Good
Findings from a pair of studies from investigators in Israel suggest that probiotic supplements may not be as beneficial as previously thought.
Gonorrhea Continues to Show High Levels of Resistance to Azithromycin Across EU
Results of the 2016 European Gonococcal Antimicrobial Surveillance Program report a steady rise in drug resistant-gonorrhea infections.
DOR/3TC/TDF is Non-Superior to EFV/FTC/TDF for Reducing HIV-1 RNA Copies at 48 Weeks
A treatment comprised of DOR/3TC/TDF was non-superior to EFV/FTC/TDF for primary efficacy but resulted in fewer adverse events.
Recalls You Should Be Aware Of—Week of September 2, 2018
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Top Infectious Disease News of the Week—September 2, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
FDA Approves New Formulation of Immune Globulin for Post-Exposure Prophylaxis of Hepatitis A & Measles
The FDA has approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.
New Hampshire Reports Legionnaires' Disease Outbreak
A Legionnaires’ disease outbreak in New Hampshire has been linked to at least 1 resort in the town of Hampton.
The Surprising Antimicrobial Power of Clay
Do ancient medicinal treatments hold potential for future antimicrobial efforts?
Flu Vaccine More Effective in Women, Study Finds
New research finds that the flu vaccine is more successful in women than in men, but the complexity of the issue makes it difficult to know exactly why that is.
Concentrations of ART in Scalp Hair Correlate with Virologic Response
Strands of hair have several advantages over plasma samples in revealing whether a person with HIV is adhering to a medication regimen.
As Ebola Case Counts Climb, Multiple Outbreaks Beat Down on the DRC
Ebola is not the only infectious disease that health officials in the Democratic Republic of the Congo are struggling with.
Combinations of Up To 5 Antibiotics May Work Against Resistant E Coli
The conventional approach to fighting resistant E coli infections typically involves the use of no more than 2 antibiotics; however, combining as many as 5 may be the trick to fighting these infections.
E coli Strain Found in Poultry Linked with Urinary Tract Infections in Humans
Investigators have found that a strain of E coli found in retail poultry products can cause a wide range of infections in people.
SHEA Issues Practical Advice for C Difficile Testing and Treatment in NICU
New practical advice for the treatment of C difficile from SHEA advises against routine testing in NICU patients with diarrhea.
For Tick-Borne Diseases, the Future Is Now: Public Health Watch
Tick-borne infections will pose significant threats in the near future, according to infectious disease experts.
Missed Opportunities for PrEP Prescribing in High-Risk Populations
Investigators find that only 48% of surveyed health care providers had ever prescribed PrEP.
Chlamydia Infections Remain High Among Young Adult Females in the United States
Although the incidence of Chlamydia trachomatis infections remains high among young women (ages 14-24), new data indicate that prevalence of the sexually-transmitted infection is decreasing.
Investigators Uncover a New Approach to Target Herpesviruses
A new study has uncovered how cytomegalovirus can bypass the body’s defense mechanisms that prevent viral infections.